A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More
Clinical trial NCT05439824 · UNKNOWN
Trial details
- NCT number
- NCT05439824
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2023-01-12
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.